These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7792665)

  • 21. Transarterial infusion chemotherapy using cisplatin-lipiodol suspension with or without embolization for unresectable hepatocellular carcinoma.
    Kawaoka T; Aikata H; Takaki S; Katamura Y; Hiramatsu A; Waki K; Takahashi S; Hieda M; Toyota N; Ito K; Chayama K
    Cardiovasc Intervent Radiol; 2009 Jul; 32(4):687-94. PubMed ID: 19444503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Intra-arterial chemotherapy in urological cancer].
    Mitsumori K; Sato K; Kato T
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):197-203. PubMed ID: 11865624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Advantages and disadvantages of SMANCS-Lipiodol intrahepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma].
    Suzuki M; Fukuhara K; Unno M; Endoh K; Takeuchi H; Kodama H; Oikawa M; Matsuno S
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():39-45. PubMed ID: 9512686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amifostine (Ethyol) as modulator of hepatic and biliary toxicity from intraarterial hepatic chemoembolization: results of a phase I study.
    Fiorentini G; Giovanis P; Leoni M; De Giorgi U; Cariello A; Dazzi C; Caldeo A
    Hepatogastroenterology; 2001; 48(38):313-6. PubMed ID: 11379297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trans-arterial infusion chemotherapy for recurrence of pleural dissemination after thymectomy.
    Terada Y; Kambayashi T; Okahashi S; Noguchi T; Kamakari K; Kubo S
    Ann Thorac Surg; 2005 May; 79(5):e32-3. PubMed ID: 15854916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of two kinds of dosages of anticancer drugs and analysis of prognostic factors.
    Lu W; Li Y; He X; Chen Y
    Hepatogastroenterology; 2003; 50(54):2079-83. PubMed ID: 14696468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparison of side effects caused by intra-arterial and intravenous infusion of M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) for urothelial cancer].
    Uchida J; Okada H; Ohguchi N; Kawa G; Koyama Y; Mikami O; Kawamura H; Ohhara T; Matsuda T
    Hinyokika Kiyo; 1997 Sep; 43(9):637-40. PubMed ID: 9365842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bisphosphonates, cancer, and osteonecrosis--a single practice experience.
    Guarino MJ; Hill CE; Patel K
    Del Med J; 2005 May; 77(5):181-7. PubMed ID: 15957261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Value of locoregional chemotherapy in liver metastases of breast carcinoma].
    Zimmermann T; Flechsenhar K; Padberg W
    Zentralbl Chir; 1998; 123 Suppl 5():159-61. PubMed ID: 10063604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Arterial infusion of SMANCS-Lipiodol for advanced hepatocellular carcinoma].
    Miura K; Nakao N; Yoshimoto A; Yamano T; Inoue J; Takayasu Y
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():51-5. PubMed ID: 9512688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pathological evaluation of superselective one-shot intra-arterial infusion chemotherapy for head and neck tumors].
    Handa T; Orita Y; Akisada T; Sato Y; Yoshihiro T; Kawai A; Aihara T; Urabe Y; Imai S; Kajihara Y; Imajo Y
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1479-81. PubMed ID: 8854785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic arterial infusion chemotherapy with use of an implanted port system in patients with advanced hepatocellular carcinoma: prognostic factors.
    Hamada A; Yamakado K; Nakatsuka A; Takaki H; Akeboshi M; Takeda K
    J Vasc Interv Radiol; 2004 Aug; 15(8):835-41. PubMed ID: 15297587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Principles of adjuvant drug therapy in breast cancer].
    Castiglione M; Schnürch HG; Bender HG; Goldhirsch A
    Gynakologe; 1994 Apr; 27(2):49-63. PubMed ID: 8039743
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hepatic arterial infusion chemotherapy (HAI) for advanced hepatocellular carcinoma inefficacious with transcatheter arterial embolization (TAE)].
    Takayama W; Asano T; Kobayashi S; Nakagouri S; Kenmochi T; Okazumi S; Takeda A; Fukunaga T; Iwasaki K; Shutou K; Matsuzaki H; Aoyama H; Shinotou K; Kouno T; Isono K
    Gan To Kagaku Ryoho; 1998 May; 25(6):867-71. PubMed ID: 9617325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cytostatic drug therapy in the aged].
    Wilmanns W
    Verh Dtsch Ges Inn Med; 1990; 96():286-94. PubMed ID: 2092446
    [No Abstract]   [Full Text] [Related]  

  • 36. The evolution of curative cancer therapy.
    Frei E
    Mt Sinai J Med; 1992 Oct; 59(5):408-11. PubMed ID: 1435837
    [No Abstract]   [Full Text] [Related]  

  • 37. Palliative chemotherapy and hormonal therapy.
    Romond EH; Metcalfe MS; Macdonald JS
    Semin Oncol; 1985 Dec; 12(4):384-9. PubMed ID: 2417323
    [No Abstract]   [Full Text] [Related]  

  • 38. [Three cases of hepatocellular carcinoma, over 3 cm in diameter, with liver cirrhosis treated with combination of radiofrequency ablation and continuous hepatic arterial infusion chemotherapy].
    Hirashita T; Nakashima K; Sakai M; Sakai I
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1123-6. PubMed ID: 17637554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Indication for local intra-arterial chemotherapy in malignant liver tumors].
    Engloner L
    Orv Hetil; 2004 Sep; 145(36):1841-3. PubMed ID: 15508402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mono-polychemotherapeutic treatment? The opportunities and limits].
    Carreca I; Dispenza J; Agueli R; Cucciarrè S
    Minerva Med; 1999; 90(7-8):203-4. PubMed ID: 10719418
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.